Literature DB >> 21213129

Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers.

Nam Soo Kim1, Yun-Jeong Kang, Jin-Ok Jo, Heung Yeol Kim, Young Rim Oh, Young-Ok Kim, Min Hyung Jung, Mee Sun Ock, Hee-Jae Cha.   

Abstract

Recent studies have shown that thymosin β4 (TB-4) is highly related with tumor metastasis and angiogenesis. In addition, TB-4 induced the expression of VEGF in melanoma cells. We investigated the expression patterns of TB-4 and related angiogenic proteins, VEGF, and HIF-1α, at various stages of cervical cancers and also identified the expression pattern of these proteins in metastatic cervical cancers. Expression patterns of TB-4, VEGF, and HIF-1α were studied with tissue microarray containing 42 samples of cervical cancers. In addition, 15 cervical cancers and metastatic tumors in lymph nodes from patients who have metastatic tumors were also analyzed to confirm the role of TB-4, VEGF, and HIF -1α in cervical cancer metastasis. The expression levels of TB-4, VEGF, and HIF-1α were very weak at early cancer stages (stages 0 to 1A) but significantly increased at stage 1B. The numbers of blood vessels in tumors were also increased at stage 1B. The expression patterns of TB-4, VEGF, and HIF-1α were compared in tumors without lymph node metastasis, primary tumors with lymph node metastasis, and metastatic tumors in lymph nodes. The expression levels of TB-4, VEGF, and HIF-1α in primary tumors with lymph node metastasis and their metastatic tumors in lymph node were less than in tumors without lymph node metastasis. These data suggest that TB-4, VEGF, and HIF-1α triggered angiogensis and tumor invasiveness to surrounding tissues at early stage of cervical carcinoma but have a negative or no effect on the metastatic potential.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213129     DOI: 10.1007/s12253-010-9327-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  30 in total

1.  Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids.

Authors:  J D Young; A J Lawrence; A G MacLean; B P Leung; I B McInnes; B Canas; D J Pappin; R D Stevenson
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

3.  Increased resistance to apoptosis in cells overexpressing thymosin beta four: A role for focal adhesion kinase pp125FAK.

Authors:  M Niu; V T Nachmias
Journal:  Cell Adhes Commun       Date:  2000-01

4.  Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells.

Authors:  Tokushige Kobayashi; Futoshi Okada; Nobuyuki Fujii; Naoko Tomita; Satoru Ito; Hiroshi Tazawa; Tetsuya Aoyama; Sung Ki Choi; Toshiyuki Shibata; Hisakazu Fujita; Masuo Hosokawa
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

5.  Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.

Authors:  H-C Huang; C-H Hu; M-C Tang; W-S Wang; P-M Chen; Y Su
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

6.  Primary surgical treatment of carcinoma stage I of the uterine cervix.

Authors:  V Falk; N Lundgren; L Quarfordt; K Arström
Journal:  Acta Obstet Gynecol Scand       Date:  1982       Impact factor: 3.636

7.  [Endostar reduces the growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer].

Authors:  Yi-tao Jia; Zhong-xin Li; Min Liu; Shu-ai Chen; Lei Zhang; Ya-di Wang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2009-04

8.  Thymosin beta 4 induces hair growth via stem cell migration and differentiation.

Authors:  Deborah Philp; Sharleen St-Surin; Hee-Jae Cha; Hye-Sung Moon; Hynda K Kleinman; Michael Elkin
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

9.  Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development.

Authors:  D Philp; A L Goldstein; H K Kleinman
Journal:  Mech Ageing Dev       Date:  2004-02       Impact factor: 5.432

10.  Expression of vascular endothelial growth factor and hypoxia inducible factor-1alpha in cervical neoplasia.

Authors:  Jae Hong No; Hoenil Jo; Su-Hyeong Kim; In-Ae Park; Daehee Kang; Seung-Su Han; Jae Weon Kim; Noh-Hyun Park; Soon-Beom Kang; Yong-Sang Song
Journal:  Ann N Y Acad Sci       Date:  2009-08       Impact factor: 5.691

View more
  10 in total

1.  Similarity in the functions of HIF-1α and HIF-2α proteins in cervical cancer cells.

Authors:  Lixia Jiang; Shaohua Shi; Qiaofa Shi; Huijuan Zhang; Rong Hu; Meizhen Wang
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

2.  Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma.

Authors:  Joo-Yun Byun; Kun Huang; Jong Suk Lee; Wenjie Huang; Li Hu; Xuyu Zheng; Xin Tang; Fengzeng Li; Dong-Gyu Jo; Xinmao Song; Chuang Huang
Journal:  Oncogene       Date:  2022-01-10       Impact factor: 8.756

3.  Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.

Authors:  Claudia Desiderio; Claudia Martelli; Diana Valeria Rossetti; Concezio Di Rocco; Luca D'Angelo; Massimo Caldarelli; Gianpiero Tamburrini; Federica Iavarone; Massimo Castagnola; Irene Messana; Tiziana Cabras; Gavino Faa
Journal:  Childs Nerv Syst       Date:  2013-03-17       Impact factor: 1.475

4.  Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.

Authors:  Nicole M A White; Daniel W Newsted; Olena Masui; Alexander D Romaschin; K W Michael Siu; George M Yousef
Journal:  Tumour Biol       Date:  2013-10-19

5.  Thymosin β4 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition.

Authors:  Xiaojun Fu; Peiyuan Cui; Fangfang Chen; Jianzhong Xu; Li Gong; Lei Jiang; Dakun Zhang; Yongtao Xiao
Journal:  Mol Med Rep       Date:  2015-02-16       Impact factor: 2.952

6.  Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.

Authors:  Kenneth W Jackson; Victoria J Christiansen; Vivek R Yadav; Robert Silasi-Mansat; Florea Lupu; Vibhudutta Awasthi; Roy R Zhang; Patrick A McKee
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

Review 7.  Putative role of HIF transcriptional activity in melanocytes and melanoma biology.

Authors:  Blazej Zbytek; Danielle L Peacock; Tiffany N Seagroves; Andrzej Slominski
Journal:  Dermatoendocrinol       Date:  2013-04-01

8.  Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis.

Authors:  Yiqin Zuo; Bongkwon Chun; Sebastian A Potthoff; Naj Kazi; Tyler J Brolin; Diclehan Orhan; Hai-Chun Yang; Li-Jun Ma; Valentina Kon; Timo Myöhänen; Nour-Eddine Rhaleb; Oscar A Carretero; Agnes B Fogo
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

9.  Expression of VEGF and HIF-1α in locally advanced cervical cancer: potential biomarkers for predicting preoperative radiochemotherapy sensitivity and prognosis.

Authors:  Pengfeng Zhu; Yangjun Ou; Yishan Dong; Peizhen Xu; Lei Yuan
Journal:  Onco Targets Ther       Date:  2016-05-23       Impact factor: 4.147

Review 10.  Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

Authors:  Giovanni Barillari; Roberto Bei; Vittorio Manzari; Andrea Modesti
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.